Narrative review: predicting future molecular and clinical profiles of prostate cancer in the United States

Prostate cancer represents the most frequent tumor in men, accounting for the 21% of all diagnosed tumors, with 191,930 new cases and 33,330 deaths estimated in 2020. Advanced prostate cancer represents a heterogeneous disease, ranging from hormone naive or hormone sensitive to castration resistant....

Descripción completa

Detalles Bibliográficos
Autores principales: Santoni, Matteo, Cimadamore, Alessia, Massari, Francesco, Sorgentoni, Giulia, Cheng, Liang, Lopez-Beltran, Antonio, Battelli, Nicola, Montironi, Rodolfo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Review Article on Update on Molecular Classification and Individualized Treatments of Genitourinary Tumors
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039584/
https://www.ncbi.nlm.nih.gov/pubmed/33850790
http://dx.doi.org/10.21037/tau-20-1439

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039584/
https://www.ncbi.nlm.nih.gov/pubmed/33850790
http://dx.doi.org/10.21037/tau-20-1439

Ejemplares similares